7Baggers
 VolitionRx (NYSE:VNRX) Receives Buy Rating from HC Wainwright  Defense World Wed, 01 Oct 2025 06:23:10 GMT
 HC Wainwright Reiterates Buy Rating for VolitionRx (NYSE:VNRX)  MarketBeat Tue, 30 Sep 2025 12:40:23 GMT
 H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50  Investing.com Tue, 30 Sep 2025 11:58:55 GMT
 VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh  GuruFocus Tue, 30 Sep 2025 11:52:09 GMT
 published on: 2025-09-30 04:28:37  newser.com Tue, 30 Sep 2025 09:28:37 GMT
 VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ  GuruFocus Mon, 29 Sep 2025 17:19:07 GMT
 VolitionRx (NYSE:VNRX) Earns Buy Rating from D. Boral Capital  MarketBeat Mon, 29 Sep 2025 17:09:14 GMT
 volitionrx, hologic to co-market nu.q discover service  MarketScreener Mon, 29 Sep 2025 15:13:01 GMT
 Volition Signs Co-Marketing and Services Agreement with Hologic  MarketScreener Mon, 29 Sep 2025 13:30:00 GMT
 Benchmark Co. Maintains VolitionRX(VNRX.US) With Hold Rating  富途牛牛 Mon, 29 Sep 2025 08:08:10 GMT
 volitionrx (vnrx) gets a hold from benchmark co.  The Globe and Mail Tue, 16 Sep 2025 07:00:00 GMT
 VolitionRX stock holds steady as Benchmark reiterates rating  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 Volitionrx CEO Reynolds buys $9,885 in company stock  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 benchmark co. maintains volitionrx(vnrx.us) with hold rating  富途牛牛 Mon, 15 Sep 2025 07:00:00 GMT
 volitionrx's (vnrx) buy rating reaffirmed at d. boral capital  MarketBeat Mon, 15 Sep 2025 03:58:05 GMT
 published on: 2025-09-13 20:09:44  newser.com Sun, 14 Sep 2025 01:09:44 GMT
 volitionrx (nyse:vnrx) given buy rating at d. boral capital  MarketBeat Fri, 12 Sep 2025 12:58:10 GMT
 VolitionRx : Short Corporate Deck, Sept 2025  MarketScreener Thu, 11 Sep 2025 05:13:06 GMT
 VolitionRX stock rating reiterated at Buy by H.C. Wainwright  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 volitionrx (vnrx) maintains "buy" rating with $5 target price |  GuruFocus Wed, 10 Sep 2025 07:00:00 GMT
 volitionrx (vnrx) enters agreement with werfen for aps research  GuruFocus Tue, 09 Sep 2025 13:22:05 GMT
 volition signs first human out licensing deal  MarketScreener Tue, 09 Sep 2025 12:59:23 GMT
 volitionrx signs first human out licensing deal for aps  TipRanks Tue, 09 Sep 2025 07:00:00 GMT

VolitionRx Limited
(NYSE MKT:VNRX) 

VNRX stock logo

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q Vet Cancer Screening Test for veterinary applications. The company also develops blood-based Nu.Q immunoassays to detect...

Founded: 1998
Full Time Employees: 50
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends